Ikegaya T, Kobayashi A, Hong R B, Masuda H, Kaneko M, Noboru Y
Third Department of Internal Medicine, Hamamatsu University School of Medicine, Japan.
Mol Cell Biochem. 1992 Mar 4;110(1):83-90. doi: 10.1007/BF02385009.
The Bio 14.6 cardiomyopathic Syrian hamster is an animal model of human idiopathic cardiomyopathy. The pathogenesis of the disease in this animal has not yet been clearly elucidated. It is well known that alpha- and beta-adrenergic receptors are increased in the myocardium of this animal, but that isoprenaline does not produce an augmented response. We examined the activity of cardiac stimulatory GTP-binding protein (Gs), which couple with beta-adrenergic receptors to stimulate adenylate cyclase, in Bio 14.6 cardiomyopathic hamsters at 90 and 160 days of age. The cardiac norepinephrine concentration was significantly increased in Bio 14.6 hamsters compared with control hamsters (F1B) at 90 days of age (1,739 +/- 120 vs 1,470 +/- 161 ng/g wet tissue weight, p less than 0.05). Cardiac forskolin-stimulated adenylate cyclase activities at 90 and 160 days of age were lower in the cardiomyopathic hamsters than in the F1B controls (90 days old: 98 +/- 24 vs 122 +/- 29 pmol/min/mg protein, p less than 0.05; 160 days old: 74 +/- 13 vs 124 +/- 28 pmol/min/mg protein, p less than 0.01). Cardiac Gs activities at 90 and 160 days of age were significantly lower in Bio 14.6 hamsters than those in F1B hamsters (90 days old: 204 +/- 42 vs 259 +/- 49 pmol/min/mg protein, p less than 0.05; 160 days old: 156 +/- 39 vs 211 +/- 60 pmol/min/mg protein, p less than 0.05). We thus demonstrated functional defects in cardiac Gs protein and adenylate cyclase activity in the Bio 14.6 cardiomyopathic hamsters at 90 to 160 days of age (the hypertrophic stage of cardiomyopathy).(ABSTRACT TRUNCATED AT 250 WORDS)
Bio 14.6心肌病叙利亚仓鼠是人类特发性心肌病的动物模型。该动物疾病的发病机制尚未完全阐明。众所周知,这种动物心肌中的α和β肾上腺素能受体增加,但异丙肾上腺素并未产生增强反应。我们检测了90日龄和160日龄的Bio 14.6心肌病仓鼠心脏刺激型GTP结合蛋白(Gs)的活性,该蛋白与β肾上腺素能受体偶联以刺激腺苷酸环化酶。与对照仓鼠(F1B)相比,90日龄的Bio 14.6仓鼠心脏去甲肾上腺素浓度显著升高(1,739±120对1,470±161 ng/g湿组织重量,p<0.05)。90日龄和160日龄时,心肌病仓鼠心脏中福斯高林刺激的腺苷酸环化酶活性低于F1B对照组(90日龄:98±24对122±29 pmol/min/mg蛋白,p<0.05;160日龄:74±13对124±28 pmol/min/mg蛋白,p<0.01)。90日龄和160日龄时,Bio 14.6仓鼠心脏Gs活性显著低于F1B仓鼠(90日龄:204±42对259±49 pmol/min/mg蛋白,p<0.05;160日龄:156±39对211±60 pmol/min/mg蛋白,p<0.05)。因此,我们证明了90至160日龄(心肌病肥厚期)的Bio 14.6心肌病仓鼠心脏Gs蛋白和腺苷酸环化酶活性存在功能缺陷。(摘要截断于250字)